. . "14110" . "49" . . "V klinickej praxi je \u010Dastou komorbiditou drogovej z\u00E1vislosti depresia, hlavne v pr\u00EDpade sekund\u00E1rnej drogovej z\u00E1vislosti u depres\u00EDvnych pacientov. Vysok\u00E1 \u00FArove\u0148 komorbidity v popul\u00E1cii (30-50 %) sa d\u00E1 vysvetli\u0165 zdie\u013Ean\u00FDmi neurobiologick\u00FDmi abnormalitami a aberantnou neuroadapt\u00E1ciou na ak\u00FAtny efekt drogy ved\u00FAcej k neurochemick\u00FDm zmen\u00E1m, ktor\u00E9 maj\u00FA spolo\u010Dn\u00E9 prvky s abnormalitami vyskytuj\u00FAcimi sa pri depresii. \u010Cl\u00E1nok poskytuje preh\u013Ead neurobiologick\u00E9ho podkladu drogovej z\u00E1vislosti a depresie so zameran\u00EDm na amfetam\u00EDnov\u00E9 psychostimulanci\u00E1." . . "RIV/00216224:14110/14:00077659" . "26"^^ . . "[774BEF0E2624]" . . . . "Common neurobiological mechanisms of depression and methamphetamine addiction"@en . . . "Drug addiction and depression is the most common comorbidity, especially in case of secondary drug addiction of patients with depression. High comorbidity in population (30-50 %) may reflect shared neurobiogical abnormalities, aberrant neuroadaptation to acute drug effect leading to neurochemical changes, which have common elements with abnormalities connected to depression. Article presents review of neurobiological background of drug addiction and depression focused on amfetamine-like psychostimulants."@en . . "2"^^ . "Spolo\u010Dn\u00E9 neurobiologick\u00E9 mechanizmy depresie a metamfetam\u00EDnovej z\u00E1vislosti" . "P(ED1.1.00/02.0068), S" . "Spolo\u010Dn\u00E9 neurobiologick\u00E9 mechanizmy depresie a metamfetam\u00EDnovej z\u00E1vislosti" . . "RIV/00216224:14110/14:00077659!RIV15-MSM-14110___" . "Babinsk\u00E1, Zuzana" . "2"^^ . "addiction; depression; psychostimulants; metamphetamine"@en . . "3" . "SK - Slovensk\u00E1 republika" . . "Common neurobiological mechanisms of depression and methamphetamine addiction"@en . . "Ku\u010Derov\u00E1, Jana" . . "0862-0350" . "46724" . "Alkoholizmus a drogov\u00E9 z\u00E1vislosti" . . .